Clinical Trial Update: GALLEX 1 - Long Term Extension Study in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

The GALLEX 1 long-term extension study in patients with type 2 diabetes mellitus (Phase 3) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 3 | Status: TERMINATED